Tollip, an early regulator of the acute inflammatory response in the substantia nigra
about
Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments.Integrin CD11b mediates α-synuclein-induced activation of NADPH oxidase through a Rho-dependent pathway.Toll-Like Receptor 2 Signaling and Current Approaches for Therapeutic Modulation in Synucleinopathies.
P2860
Tollip, an early regulator of the acute inflammatory response in the substantia nigra
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tollip, an early regulator of the acute inflammatory response in the substantia nigra
@en
Tollip, an early regulator of the acute inflammatory response in the substantia nigra.
@nl
type
label
Tollip, an early regulator of the acute inflammatory response in the substantia nigra
@en
Tollip, an early regulator of the acute inflammatory response in the substantia nigra.
@nl
prefLabel
Tollip, an early regulator of the acute inflammatory response in the substantia nigra
@en
Tollip, an early regulator of the acute inflammatory response in the substantia nigra.
@nl
P2093
P2860
P50
P1476
Tollip, an early regulator of the acute inflammatory response in the substantia nigra
@en
P2093
F Monnet-Tschudi
J Sandström von Tobel
M H Maillard
P2860
P2888
P356
10.1186/S12974-016-0766-5
P577
2016-12-07T00:00:00Z
P6179
1027211795